project id: TCGA-CESC; case submitter id: TCGA-EK-A2RJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.74; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 9.3; age at index: 51; days to birth: -18664; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 18664; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 53.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 714; initial weight: 130.0; oct embedded: false; preservation method: Unknown; sample id: 9492d265-9f48-4b2f-9344-a0604939b23c; sample submitter id: TCGA-EK-A2RJ-01A; portion id: b946f3de-0f4a-4d7a-bc3b-6909ad5b7b1f; portion submitter id: TCGA-EK-A2RJ-01A-11; slide id: e2452d4d-be00-4930-a06d-568ee8e34502; slide submitter id: TCGA-EK-A2RJ-01A-01-TS1; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 12.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 86.0; percent tumor nuclei: 70.0; section location: TOP;